:::

詳目顯示

回上一頁
題名:Medical Expenditure and Its Impact Factors among Patients with Diabetes and Diabetic Nephropathy in Taiwan by Two-part Model with Lasso Penalty
書刊名:品質學報
作者:陳銘芷葉玲瓏姜葉飛黃彥鈞謝邦昌李天行
作者(外文):Chen, MingchihYe, LinglongJiang, YefeiHuang, Yen-chunShia, Ben-changLee, Tian-shyug
出版日期:2022
卷期:29:5
頁次:頁412-428
主題關鍵詞:醫療費用糖尿病糖尿病腎病變Lasso二部模型Medical costDiabetesDiabetic nephropathyTwo-part model with Lasso penalty
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:3
期刊論文
1.Liu, L. F.、Tian, W. H.、Yao, H. P.(2012)。Utilization of Health Care Services by Elderly People with National Health Insurance in Taiwan: The Heterogeneous Health Profile Approach。Health Policy,108(2/3),246-255。  new window
2.Levey, A. S.、Coresh, J.(2012)。Chronic kidney disease。The lancet,379(9811),165-180。  new window
3.Tibshirani, R.(1996)。Regression Shrinkage and Selection via the LASSO。Journal of the Royal Statistical Society: Series B (Methodological),58(1),267-288。  new window
4.Jha, V.、Garcia-Garcia, G.、Iseki, K.、Li, Z.、Naicker, S.、Plattner, B.、Saran, R.、Wang, A. Y.、Yang, C. W.(2013)。Chronic kidney disease: Global dimension and perspectives。The Lancet,382(9888),260-272。  new window
5.Hsu, C. C.、Hwang, S. J.、Wen, C. P.、Chang, H. Y.、Chen, T.、Shiu, R. S.、Yang, W. C.(2006)。High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative Survey。American Journal of Kidney Diseases,48(5),727-738。  new window
6.Chan, T. C.、Fan, I. C.、Liu, M. S.-Y.、Su, M. D.、Chiang, P. H.(2014)。Addressing health disparities in chronic kidney disease。International Journal of Environmental Research and Public Health,11(12),12848-12865。  new window
7.Hwang, S. J.、Tsai, J. C.、Chen, H. C.(2010)。Epidemiology, impact and preventive care of chronic kidney disease in Taiwan。Nephrology,15(Suppl. 2),3-9。  new window
8.Duan, N.、Manning, W. G. Jr.、Morris, C. N.、Newhouse, J. P.(1983)。A comparison of alternative models for the demand for medical care。Journal of Business & Economic Statistics,1(2),115-126。  new window
9.Guariguata, L.、Whiting, D. R.、Hambleton, I.、Beagley, J.、Linnenkamp, U.、Shaw, J. E.(2014)。Global estimates of diabetes prevalence for 2013 and projections for 2035。Diabetes Research and Clinical Practice,103(2),137-149。  new window
10.Hsieh, M. C.、Hsieh, Y. T.、Cho, T. J.、Chen, J. F.、Lin, S. D.、Chen, H. C.、Tu, S. T.(2011)。Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control。European Journal of Clinical Investigation,41(8),870-878。  new window
11.Yang, W. C.、Hwang, S. J.、Chiang, S. S.、Chen, H. F.、Tsai, S. T.(2001)。The impact of diabetes on economic costs in dialysis patients: Experiences in Taiwan。Diabetes Research and Clinical Practice,54(Suppl 1),47-54。  new window
12.Tobin, James(1958)。Estimation of relationships for limited dependent variables。Econometrica: Journal of the Econometric Society,26(1),24-36。  new window
13.Chen, J.-S.、Lu, C.-L.、Huang, L.-C.、Shen, C.-H.、Chen, S. C.-C.(2016)。Chronic kidney disease is associated with upper tract urothelial carcinoma--a nationwide population-based cohort study in Taiwan。Urological Science,27(2 Suppl. 1)。  new window
14.Fried, L. F.、Emanuele, N.、Zhang, J. H.、Brophy, M.、Conner, T. A.、Duckworth, W.(2013)。Combined angiotensin inhibition for the treatment of diabetic nephropathy。New England Journal of Medicine,369(20),1892-1903。  new window
15.Jandeleit-Dahm, K.、Cao, Z.、Cox, A. J.、Kelly, D. J.、Gilbert, R. E.、Cooper, M. E.(1999)。Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy。Kidney International,56(Suppl. 71),S31-S36。  new window
16.Kang, J.-H.、Ho, J.-D.、Chen, Y.-H.、Lin, H.-C.(2009)。Increased risk of stroke after a herpes zoster attack: a population-based follow-up study。Stroke,40(11),3443-3448。  new window
圖書
1.許志成、吳麥斯、熊昭、黃尚志、林裕峯、許永和(2018)。2017台灣腎病年報。苗栗縣:財團法人國家衛生研究院。  延伸查詢new window
其他
1.National Center for Health Statistics(2021)。International classification of diseases, ninth revision, clinical modification (ICD-9-CM),http://www.cdc.gov/nchs/icd/icd9cm.htm。  new window
2.衛生福利部中央健康保險署(2022)。慢性腎臟病防治,https://www.nhi.gov.tw/Content_List.aspx?n=D5CC89AE36D48E5E&topn=CA428784F9ED78C9。  延伸查詢new window
圖書論文
1.Maric, C.、Hall, J. E.(2011)。Obesity, metabolic syndrome and diabetic nephropathy。Diabetes and the Kidney。S. Karger AG。  new window
2.Reutens, A. T.、Atkins, R. C.(2011)。Epidemiology of diabetic nephropathy。Diabetes and the Kidney。S. Karger AG。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
QR Code
QRCODE